Anthony Fenton

792 total citations
21 papers, 484 citations indexed

About

Anthony Fenton is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anthony Fenton has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 3 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anthony Fenton's work include Chronic Kidney Disease and Diabetes (12 papers), Dialysis and Renal Disease Management (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Anthony Fenton is often cited by papers focused on Chronic Kidney Disease and Diabetes (12 papers), Dialysis and Renal Disease Management (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Anthony Fenton collaborates with scholars based in United Kingdom, Denmark and United States. Anthony Fenton's co-authors include Paul Cockwell, Charles J. Ferro, Mark Jesky, M.A. Karsdal, Federica Genovese, Indranil Dasgupta, Daniel Guldager Kring Rasmussen, Melanie Calvert, Peter Nightingale and Derek Kyte and has published in prestigious journals such as PLoS ONE, Scientific Reports and PLoS Medicine.

In The Last Decade

Anthony Fenton

21 papers receiving 473 citations

Peers

Anthony Fenton
Mark Jesky United Kingdom
Stephanie Stringer United Kingdom
M.A. Dooley United States
Punit Yadav United Kingdom
Robert B. Huizinga United States
Eline Houben Netherlands
Mark Jesky United Kingdom
Anthony Fenton
Citations per year, relative to Anthony Fenton Anthony Fenton (= 1×) peers Mark Jesky

Countries citing papers authored by Anthony Fenton

Since Specialization
Citations

This map shows the geographic impact of Anthony Fenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Fenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Fenton more than expected).

Fields of papers citing papers by Anthony Fenton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Fenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Fenton. The network helps show where Anthony Fenton may publish in the future.

Co-authorship network of co-authors of Anthony Fenton

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Fenton. A scholar is included among the top collaborators of Anthony Fenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Fenton. Anthony Fenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Katherine W., Jonathan Hazlehurst, Srikanth Bellary, et al.. (2023). Inequalities in the management of diabetic kidney disease in UK primary care: A cross‐sectional analysis of a large primary care database. Diabetic Medicine. 41(1). e15153–e15153. 5 indexed citations
2.
Fenton, Anthony, et al.. (2022). Use of the kidney failure risk equation to inform clinical care of patients with chronic kidney disease: a mixed-methods systematic review. BMJ Open. 12(1). e055572–e055572. 11 indexed citations
3.
Cockwell, Paul, Anuradhaa Subramanian, Nicola J. Adderley, et al.. (2021). Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom. Kidney International Reports. 6(8). 2189–2199. 23 indexed citations
4.
Fenton, Anthony, Rajkumar Chinnadurai, Indranil Dasgupta, et al.. (2020). Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study. PLoS Medicine. 17(2). e1003050–e1003050. 3 indexed citations
5.
Sharma, Praveen, Anthony Fenton, Irundika H.K. Dias, et al.. (2020). Oxidative stress links periodontal inflammation and renal function. Journal Of Clinical Periodontology. 48(3). 357–367. 46 indexed citations
6.
Chanouzas, Dimitrios, Anthony Fenton, Paul Moss, et al.. (2019). Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease. QJM. 113(4). 253–257. 3 indexed citations
7.
Genovese, Federica, Daniel Guldager Kring Rasmussen, M.A. Karsdal, et al.. (2019). Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients. Clinical Kidney Journal. 14(2). 593–601. 23 indexed citations
8.
Fenton, Anthony, Stuart W. Smith, & Peter Hewins. (2018). Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes. BMC Nephrology. 19(1). 207–207. 25 indexed citations
9.
Fenton, Anthony, Mark Jesky, Rachel Webster, et al.. (2018). Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease. PLoS ONE. 13(5). e0197043–e0197043. 6 indexed citations
10.
Nielsen, Signe Holm, Daniel Guldager Kring Rasmussen, Susanne Brix, et al.. (2018). A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease. PLoS ONE. 13(10). e0204239–e0204239. 16 indexed citations
11.
Fenton, Anthony, et al.. (2018). Glomerular filtration rate: new age- and gender- specific reference ranges and thresholds for living kidney donation. BMC Nephrology. 19(1). 336–336. 53 indexed citations
12.
Taylor, Angela E., Anthony Fenton, Dimitrios Chanouzas, et al.. (2018). Glucocorticoid activation by 11β‐hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross‐sectional study. Clinical Endocrinology. 90(1). 241–249. 19 indexed citations
13.
Fraser, Simon, Anthony Fenton, Scott Harris, et al.. (2017). The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysis. Mayo Clinic Proceedings. 92(11). 1671–1681. 12 indexed citations
14.
Rasmussen, Daniel Guldager Kring, Anthony Fenton, Mark Jesky, et al.. (2017). Urinary endotrophin predicts disease progression in patients with chronic kidney disease. Scientific Reports. 7(1). 17328–17328. 53 indexed citations
15.
Fenton, Anthony, Mark Jesky, Charles J. Ferro, et al.. (2017). Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease. PLoS ONE. 12(4). e0175200–e0175200. 58 indexed citations
16.
Jesky, Mark, Mary Ann Dutton, Indranil Dasgupta, et al.. (2016). Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study. PLoS ONE. 11(11). e0165675–e0165675. 53 indexed citations
17.
Jesky, Mark, Stephanie Stringer, Anthony Fenton, et al.. (2016). Serum tryptase concentration and progression to end‐stage renal disease. European Journal of Clinical Investigation. 46(5). 460–474. 21 indexed citations
18.
Fenton, Anthony, et al.. (2010). Multidisciplinary Care Improves Outcome of Patients with Stage 5 Chronic Kidney Disease. Nephron Clinical Practice. 115(4). c283–c288. 20 indexed citations
19.
Fenton, Anthony, et al.. (2005). Canada in Haiti : waging war on the poor majority. Medical Entomology and Zoology. 15 indexed citations
20.
Fenton, Anthony, et al.. (1989). Prognostic Indicators in Tibial Shaft Fractures. Journal of Orthopaedic Trauma. 3(4). 345–347. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026